Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.880
-0.040 (-2.08%)
Dec 5, 2025, 4:00 PM EST - Market closed
Seer, Inc. Revenue
Seer, Inc. had revenue of $4.12M in the quarter ending September 30, 2025, with 2.21% growth. This brings the company's revenue in the last twelve months to $16.38M, up 12.11% year-over-year. In the year 2024, Seer, Inc. had annual revenue of $14.17M, down -14.95%.
Revenue (ttm)
$16.38M
Revenue Growth
+12.11%
P/S Ratio
6.68
Revenue / Employee
$122,216
Employees
134
Market Cap
104.88M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SEER News
- 5 days ago - Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers - GlobeNewsWire
- 4 weeks ago - Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 - GlobeNewsWire
- 4 weeks ago - Seer, Inc. (SEER) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Seer Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Seer to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 7 weeks ago - Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 2 months ago - Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 - GlobeNewsWire
- 3 months ago - Seer, Inc. (SEER) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha